Top Stories

World watches as first person receives Pfizer-BioNTech COVID shot


Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca

and the University of Oxford will be delivered to the U.K., falling short of the 30 million doses the country had hoped to receive by the end of the year.

News of the shortfall comes as the U.K. became the first country to embark on a mass immunization program, with National Health Service hospitals on Tuesday starting to administer 800,000 shots of the vaccine developed by U.S. drugmaker Pfizer

and its German partner BioNTech

U.K. regulators…


FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria

Previous article

Wealthfront names Sheila Bair and Thomas Curry to banking advisory group

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories